CMS waives hospitalization requirement for SNF patients
The Centers for Medicare & Medicaid Services (CMS) has announced it will waive several requirements for SNF residents impacted by COVID-19. The measures, which were announced at the end of April, are intended to help facilities adapt quickly to accommodate residents and to help ensure residents are eligible for needed benefits in light of the COVID-19 pandemic.
Some of the waivers related to SNF patients include:
With the blanket waiver, patients will be eligible for CMS coverage without the usual prerequisite of three days of prior hospitalization if they have been displaced or been affected by COVID-19.
Renewal of benefits
The provision also allows residents who have exhausted their long-term care benefits to renew their SNF benefits without having to begin a new benefit period if they were prevented from completing and renewing their previous benefits due to the coronavirus crisis. To be eligible, their benefits must have been renewable under normal circumstances.
Pre-admission screening and annual reviews
With the waivers, SNFs will be able to admit patients who have not yet had their Level 1 or Level 2 admissions screenings. Instead, facilities will have up to 30 days after admitting patients to perform the required screenings.
To allow facilities to create cohorts to care for residents who have been diagnosed with COVID-19, CMS is waiving several transfer requirements, as long as a facility has agreed to receive a resident from another facility. Cohort agreements can allow for the transfer of residents with COVID-19 to allow stricken residents to be isolated in one facility, or residents who test negative for the illness can be transferred to other facilities to protect them from a COVID-19 outbreak within their current facility.
Blanket waivers automatically go into effect, so facilities do not need to submit applications when they take advantage of the waived requirements.
With these waivers, facilities must continue to track infections and infection control measures. Find out how ABILITY INFECTIONWATCH can help your staff track all of the necessary data.
Director, CMS Quality Safety & Oversight Group, April 24, 2020, memorandum to State Survey Agency Directors. https://www.cms.gov/files/document/qso-20-28-nh.pdf
Inovalon and design®, Inovalon® and ABILITY INFECTIONWATCH® are trademarks of Inovalon, Inc.